Quantitative proteomic identification of the BRCA1 ubiquitination substrates

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• The BRCA1 tumor suppressor gene is crucial for preventing hereditary breast and ovarian cancers.
• BRCA1 functions as a heterodimer with BARD1, exhibiting ubiquitin ligase activity vital for DNA damage response and tumor suppression.
• Identifying specific BRCA1 substrates has been challenging, hindering a full understanding of its cellular roles.

Purpose of the Study:

• To systematically identify protein substrates of the BRCA1 ubiquitin ligase.
• To develop and apply a novel quantitative proteomics approach for substrate discovery.
• To elucidate the functional consequences of BRCA1-mediated ubiquitination.

Main Methods:

• Development of a quantitative proteomics strategy to identify proteins with enhanced His-tagged ubiquitin incorporation upon coexpression with BRCA1.
• Systematic screening for BRCA1 substrates using the developed methodology.
• Validation of identified substrates and investigation of their functional interactions with BRCA1.

Main Results:

• Identification of several candidate BRCA1 substrates, including Scaffold Attachment Factor B2 (SAFB2), Tel2, and BARD1.
• Demonstration that BRCA1 enhances SAFB protein expression.
• Observation that BRCA1 induces nuclear translocation of Tel2.

Conclusions:

• The developed quantitative proteomics approach is effective for identifying ubiquitin ligase substrates.
• The identified substrates (SAFB2, Tel2, BARD1) provide new insights into BRCA1's functions in DNA repair and tumor suppression.
• This work facilitates the broader identification of ubiquitin ligase-substrate pairs, advancing the field of ubiquitination biology.